Respiratory Care Device Market Report and Forecast 2025-2034
Description
The global respiratory care device market reached a value of around USD 21.67 Billion in 2024, fuelled by the rise in severe respiratory diseases across the globe. The market is expected to grow at a CAGR of 8.60% during the forecast period of 2025-2034 and expected to attain a market value of around USD 49.45 Billion by 2034.
Global Respiratory Care Device Market Overview
Respiratory devices refer to equipment used in the medical field to assist people with breathing complications. These include medical oxygen concentrators, nebulizers, and ventilators. It works to help patients with various respiratory diseases like chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), fibrosis, and asthma.
The market is driven by increasing prevalence of respiratory conditions, leading to heightened use of such devices. The sudden outbreak of COVID-19 also impacted the market significantly and led to a higher demand for personal protective equipment (PPE) and ventilators.
Global Respiratory Care Device Market Growth Drivers
Burgeoning Cases of Respiratory Illnesses are Expected to Drive the Market Growth
COPD and asthma are common respiratory illnesses that increasing globally. The rising incidence of such diseases has raised the need for respiratory monitoring equipment significantly. As a result, Advancements have been made in portable nebulizers and smart inhalers. Such advancements can help patients follow the treatment plan as well as improve outcomes. Rising awareness of respiratory health and global aging also boosts demand for these devices.
Technological Advancements Boosts the Market Growth
The advancement of technology plays a crucial role in the global market. Some innovations in respiratory care have boosted patient care and healthcare delivery. They include better ventilators, nebulizers, and portable oxygen concentrators. AI and machine learning are becoming more important in diagnosing respiratory diseases. They can improve the patient’s experience by enabling better healthcare processes and decision support. This support can offer more accurate and personalized treatment suggestions. So, these technologies are driving market growth.
Global Respiratory Care Device Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Telemedicine and Remote Monitoring
Telemonitoring services and remote treatment are changing the global market by providing real-time access to lung function and the overall state from a distance. These technologies can help patients. They offer access to vital medical facilities, making it easier for patients to connect with healthcare professionals. Integration of remote monitoring in respiratory care devices can help with effective chronic respiratory disease management. This trend is also driven by adoption of new wearable tech.
Personalized and Precision Medicine
Significant development has been realized in respiratory care through personalized and precision medicine. In many clinical uses, genetic information coupled with advanced diagnostics and therapies can personalize treatment for each patient. This leads to better results and fewer side effects. It enables early disease diagnosis and effective management. Incorporation of advanced genomics and molecular biology are likely to improve diagnosis and subsequent therapy.
Increasing Government Initiatives
Public health policies around the world are enhancing the health system. Demand for prevention, diagnostics, and treatments is largely driving related policies. For instance, the Centers for Disease Control and Prevention (CDC) made a toolkit to guide hospitals in creating an effective respiratory protection program. Companies are partnering with governments and healthcare institutions to develop new solutions. Governments are also developing smoking ban advertising campaigns, immunization drives, and anti-air pollution measures to lower the rates of respiratory diseases.
COVID-19 Impact
The market also experienced a great effect from the COVID-19 pandemic. Hospitals worldwide faced shortage for effective equipment. This triggered an unprecedented demand for respiratory care equipment. Moreover, the pandemic forced healthcare practitioners to rely more on telehealth services.
Recent Development in the Global Respiratory Care Device Market
In March 2024, Medline, a well-established supplier of medical equipment and solutions, won the license for AG Cuffill and intellectual properties from Hospitech Respiration Ltd. AG Cuffill is a small easy-to-use device and measures the pressure and volume of airway cuffs consistently in clinical practice. This move expands Medline’s product offering and aims to help healthcare professionals track airway cuffs. This will reduce medical adverse effects and improve individual situations.
In February 2024 -Aircurve 11 series of ResMed utilized inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP) along with digital features. Such innovative designs are especially valuable for healthcare practitioners and patients, making it easier to diagnose and treat sleep apnea. This device has better features and navigation, which will improve therapy benefits and increase satisfaction in sleep apnea.
Global Respiratory Care Device Market Segmentation
Respiratory Care Device Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Positive Airway Pressure (PAP) Devices
Oxygen Concentrator
Ventilators
Inhalers
Nebulizers
Humidifiers
Reusable Resuscitators
Nitric Oxide Delivery Units
Oxygen Hoods Pulse Oximeter
Capnography
Gas Analyzers Spirometer
Polysomnography Devices
Peak Flow Meter
Others
Market Breakup by Disease Indications
Market Share by Product Type Poised for Growth
Based on the product, the market is further segmented into therapeutic respiratory care devices (positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, reusable resuscitators, nitric oxide delivery units and oxygen hoods), along with respiratory care monitoring devices (pulse oximeter, capnography, gas analyzers) and diagnostic respiratory care devices (spirometer, polysomnography devices, peak flow meter, others). Out of these therapeutic applications, inhalers, ventilators, and nebulizers are some of the key monitoring devices that dominate the market because of application in COPD and asthma treatment.
Self-usage inhalers and nebulizers are now more accessible globally. They meet the needs of aging people and the rise of chronic respiratory diseases. They allow for easy drug and protein delivery to the lungs. Other products, like pulse oximeters and gas analyzers, are also poised to experience growth. This can be due to their non-invasive respiratory health checks and accurate data tracking.
Market Segmentation Based on the Disease Indications Set to Drive Market Growth
Based on disease indications, the market is further segmented into COPD, asthma, sleep apnea, infectious diseases, and others. Among these, COPD stands out as the predominant segment and is the third-largest cause of death globally. Cigarette smoking remains the leading cause of COPD, with at least 70% of patients worldwide affected by it. Around 30-40% of affected individuals are present in low- and middle-income countries (LMICs). Household pollution also adds to the problem and lead to growth in COPD cases. Respiratory care devices actively help healthcare systems worldwide to meet the needs of patients with COPD and other respiratory disorders, leading to continuous market growth.
Global Respiratory Care Device Market by Region
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa are all included in the regional market analysis. North America is expected to dominate the market because of its strong healthcare system, rising respiratory disorders, and increased use of advanced technologies. This leadership is supported by ongoing research and a proactive approach to utilizing better respiratory care solutions. In addition, the region offers strategic pro-employer reimbursement policies. However, the Asia Pacific region is likely to register noticeable growth in the forecast period. Rising awareness of respiratory health, high health costs, and population growth are major factors impacting the market value. The development of various healthcare facilities in emerging economies like India and China will boost the adoption of advanced respiratory care devices, creating new opportunities for regional expansion.
Leading Players in the Global Respiratory Care Device Market
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives including recent partnerships, and collaborations between the leading players. The major companies in the market are as follows:
Koninklijke Philips N.V
The Eindhoven-based company started its journey in 1891. It is an innovative company in respiratory care devices and sleep apnea therapies. Their products and services include the number of ventilators including the V60 Plus ventilator, Trilogy EV 300 ventilator, etc.
Masimo Corporation
Founded in 1989 and based in California, U.S. This company offers different respiratory care devices and technologies for hospitals. Their products include pulse oximeters, pulse co-oximeters, and rainbow acoustic monitoring.
Teleflex Incorporated
It is American company established in 1943 and headquartered in Pennsylvania. It specializes in providing medical equipment for critical care and surgery procedures. The company focuses on researching, developing, manufacturing, and marketing disposable medical technology products.
Fisher & Paykel Healthcare Corporation Limited
Based in East Tamaki, Auckland, this company was established in 1934. The company offers various respiratory devices such as AirVO2, CPAP, etc.
Other companies in the market include Hamilton Medical AG, ICU Medical Inc., General Electric Company, ResMed Inc., Getinge AB, Aerin Medical Inc., and VitalAire Canada Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in the Global Respiratory Care Device Market Report
Global Respiratory Care Device Market Overview
Respiratory devices refer to equipment used in the medical field to assist people with breathing complications. These include medical oxygen concentrators, nebulizers, and ventilators. It works to help patients with various respiratory diseases like chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), fibrosis, and asthma.
The market is driven by increasing prevalence of respiratory conditions, leading to heightened use of such devices. The sudden outbreak of COVID-19 also impacted the market significantly and led to a higher demand for personal protective equipment (PPE) and ventilators.
Global Respiratory Care Device Market Growth Drivers
Burgeoning Cases of Respiratory Illnesses are Expected to Drive the Market Growth
COPD and asthma are common respiratory illnesses that increasing globally. The rising incidence of such diseases has raised the need for respiratory monitoring equipment significantly. As a result, Advancements have been made in portable nebulizers and smart inhalers. Such advancements can help patients follow the treatment plan as well as improve outcomes. Rising awareness of respiratory health and global aging also boosts demand for these devices.
Technological Advancements Boosts the Market Growth
The advancement of technology plays a crucial role in the global market. Some innovations in respiratory care have boosted patient care and healthcare delivery. They include better ventilators, nebulizers, and portable oxygen concentrators. AI and machine learning are becoming more important in diagnosing respiratory diseases. They can improve the patient’s experience by enabling better healthcare processes and decision support. This support can offer more accurate and personalized treatment suggestions. So, these technologies are driving market growth.
Global Respiratory Care Device Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Telemedicine and Remote Monitoring
Telemonitoring services and remote treatment are changing the global market by providing real-time access to lung function and the overall state from a distance. These technologies can help patients. They offer access to vital medical facilities, making it easier for patients to connect with healthcare professionals. Integration of remote monitoring in respiratory care devices can help with effective chronic respiratory disease management. This trend is also driven by adoption of new wearable tech.
Personalized and Precision Medicine
Significant development has been realized in respiratory care through personalized and precision medicine. In many clinical uses, genetic information coupled with advanced diagnostics and therapies can personalize treatment for each patient. This leads to better results and fewer side effects. It enables early disease diagnosis and effective management. Incorporation of advanced genomics and molecular biology are likely to improve diagnosis and subsequent therapy.
Increasing Government Initiatives
Public health policies around the world are enhancing the health system. Demand for prevention, diagnostics, and treatments is largely driving related policies. For instance, the Centers for Disease Control and Prevention (CDC) made a toolkit to guide hospitals in creating an effective respiratory protection program. Companies are partnering with governments and healthcare institutions to develop new solutions. Governments are also developing smoking ban advertising campaigns, immunization drives, and anti-air pollution measures to lower the rates of respiratory diseases.
COVID-19 Impact
The market also experienced a great effect from the COVID-19 pandemic. Hospitals worldwide faced shortage for effective equipment. This triggered an unprecedented demand for respiratory care equipment. Moreover, the pandemic forced healthcare practitioners to rely more on telehealth services.
Recent Development in the Global Respiratory Care Device Market
In March 2024, Medline, a well-established supplier of medical equipment and solutions, won the license for AG Cuffill and intellectual properties from Hospitech Respiration Ltd. AG Cuffill is a small easy-to-use device and measures the pressure and volume of airway cuffs consistently in clinical practice. This move expands Medline’s product offering and aims to help healthcare professionals track airway cuffs. This will reduce medical adverse effects and improve individual situations.
In February 2024 -Aircurve 11 series of ResMed utilized inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP) along with digital features. Such innovative designs are especially valuable for healthcare practitioners and patients, making it easier to diagnose and treat sleep apnea. This device has better features and navigation, which will improve therapy benefits and increase satisfaction in sleep apnea.
Global Respiratory Care Device Market Segmentation
Respiratory Care Device Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Therapeutic Respiratory Care Devices
- Respiratory Care Monitoring Devices
- Diagnostic Respiratory Care Devices
Market Breakup by Disease Indications
- COPD
- Asthma
- Sleep Apnea
- Infectious Disease
- Others
- Hospitals
- Home Care
- Ambulatory Care
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Share by Product Type Poised for Growth
Based on the product, the market is further segmented into therapeutic respiratory care devices (positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, reusable resuscitators, nitric oxide delivery units and oxygen hoods), along with respiratory care monitoring devices (pulse oximeter, capnography, gas analyzers) and diagnostic respiratory care devices (spirometer, polysomnography devices, peak flow meter, others). Out of these therapeutic applications, inhalers, ventilators, and nebulizers are some of the key monitoring devices that dominate the market because of application in COPD and asthma treatment.
Self-usage inhalers and nebulizers are now more accessible globally. They meet the needs of aging people and the rise of chronic respiratory diseases. They allow for easy drug and protein delivery to the lungs. Other products, like pulse oximeters and gas analyzers, are also poised to experience growth. This can be due to their non-invasive respiratory health checks and accurate data tracking.
Market Segmentation Based on the Disease Indications Set to Drive Market Growth
Based on disease indications, the market is further segmented into COPD, asthma, sleep apnea, infectious diseases, and others. Among these, COPD stands out as the predominant segment and is the third-largest cause of death globally. Cigarette smoking remains the leading cause of COPD, with at least 70% of patients worldwide affected by it. Around 30-40% of affected individuals are present in low- and middle-income countries (LMICs). Household pollution also adds to the problem and lead to growth in COPD cases. Respiratory care devices actively help healthcare systems worldwide to meet the needs of patients with COPD and other respiratory disorders, leading to continuous market growth.
Global Respiratory Care Device Market by Region
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa are all included in the regional market analysis. North America is expected to dominate the market because of its strong healthcare system, rising respiratory disorders, and increased use of advanced technologies. This leadership is supported by ongoing research and a proactive approach to utilizing better respiratory care solutions. In addition, the region offers strategic pro-employer reimbursement policies. However, the Asia Pacific region is likely to register noticeable growth in the forecast period. Rising awareness of respiratory health, high health costs, and population growth are major factors impacting the market value. The development of various healthcare facilities in emerging economies like India and China will boost the adoption of advanced respiratory care devices, creating new opportunities for regional expansion.
Leading Players in the Global Respiratory Care Device Market
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives including recent partnerships, and collaborations between the leading players. The major companies in the market are as follows:
Koninklijke Philips N.V
The Eindhoven-based company started its journey in 1891. It is an innovative company in respiratory care devices and sleep apnea therapies. Their products and services include the number of ventilators including the V60 Plus ventilator, Trilogy EV 300 ventilator, etc.
Masimo Corporation
Founded in 1989 and based in California, U.S. This company offers different respiratory care devices and technologies for hospitals. Their products include pulse oximeters, pulse co-oximeters, and rainbow acoustic monitoring.
Teleflex Incorporated
It is American company established in 1943 and headquartered in Pennsylvania. It specializes in providing medical equipment for critical care and surgery procedures. The company focuses on researching, developing, manufacturing, and marketing disposable medical technology products.
Fisher & Paykel Healthcare Corporation Limited
Based in East Tamaki, Auckland, this company was established in 1934. The company offers various respiratory devices such as AirVO2, CPAP, etc.
Other companies in the market include Hamilton Medical AG, ICU Medical Inc., General Electric Company, ResMed Inc., Getinge AB, Aerin Medical Inc., and VitalAire Canada Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in the Global Respiratory Care Device Market Report
- What was the global respiratory care device market value in 2024?
- What is the global respiratory care device market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on products?
- What is the market segmentation based on disease indications?
- What are the end users in the market?
- What are the major factors aiding the global respiratory care device market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major global respiratory care device market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the respiratory care device market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
- What are the leading types of positive airway pressure (PAP) devices in the respiratory care device market?
- How are pulse oximeters revolutionizing respiratory monitoring?
- What are the key features of peak flow meters and their importance in respiratory diagnosis?
- What are the primary drivers of demand for respiratory care devices in COPD management?
- What advancements are seen in respiratory devices for sleep apnea diagnosis and treatment?
- How are hospitals integrating respiratory care devices into patient care pathways?
- What factors are driving the demand for respiratory care devices in North America?
- What are the key growth opportunities for respiratory care devices in the Asia Pacific region?
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Respiratory Care Device Market Overview
- 3.1 Global Respiratory Care Device Market Historical Value (2018-2024)
- 3.2 Global Respiratory Care Device Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Respiratory Care Device Market Landscape*
- 5.1 Global Respiratory Care Device: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Respiratory Care Device: Product Landscape
- 5.2.1 Analysis by Type
- 5.2.2 Analysis by Disease Indication
- 6 Global Respiratory Care Device Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Respiratory Care Device Market, Epidemiology Snapshot
- 7.1 Overview of Global Respiratory Disease Incidence Number (2018-2034)
- 7.2 Incidence Number, By Indication (2018-2034)
- 7.2.1 COPD
- 7.2.1.1 Asthma
- 7.2.1.2 Sleep Apnea
- 7.2.1.3 Infectious Disease
- 7.2.1.4 Others
- 8 Global Respiratory Care Device Market Segmentation (218-2034)
- 8.1 Global Respiratory Care Device Market (2018-2034) by Product
- 8.1.1 Market Overview
- 8.1.2 Therapeutic Respiratory Care Devices
- 8.1.2.1 Positive Airway Pressure (PAP) Devices
- 8.1.2.2 Oxygen Concentrator
- 8.1.2.3 Ventilators
- 8.1.2.4 Inhalers
- 8.1.2.5 Nebulizers
- 8.1.2.6 Humidifiers
- 8.1.2.7 Reusable Resuscitators
- 8.1.2.8 Nitric Oxide Delivery Units
- 8.1.2.9 Oxygen Hoods
- 8.1.3 Respiratory Care Monitoring Devices
- 8.1.3.1 Pulse Oximeter
- 8.1.3.2 Capnography
- 8.1.3.3 Gas Analyzers
- 8.1.4 Diagnostic Respiratory Care Devices
- 8.1.4.1 Spirometer
- 8.1.4.2 Polysomnography Devices
- 8.1.4.3 Peak Flow Meter
- 8.1.4.4 Others
- 8.2 Global Respiratory Care Device Market (2018-2034) by Disease Indications
- 8.2.1 Market Overview
- 8.2.2 COPD
- 8.2.3 Asthma
- 8.2.4 Sleep Apnea
- 8.2.5 Infectious Disease
- 8.2.6 Others
- 8.3 Global Respiratory Care Device Market (2018-2034) by End User
- 8.3.1 Market Overview
- 8.3.2 Hospitals
- 8.3.3 Home Care
- 8.3.4 Ambulatory Care
- 8.3.5 Others
- 8.4 Global Respiratory Care Device Market (2018-2034) by Region
- 8.4.1 Market Overview
- 8.4.2 North America
- 8.4.3 Europe
- 8.4.4 Asia Pacific
- 8.4.5 Latin America
- 8.4.6 Middle East and Africa
- 9 North America Respiratory Care Device Market (218-2034)
- 9.1 North America Respiratory Care Device Market (2018-2034) by Product
- 9.1.1 Market Overview
- 9.1.2 Therapeutic Respiratory Care Devices
- 9.1.2.1 Positive Airway Pressure (PAP) Devices
- 9.1.2.2 Oxygen Concentrator
- 9.1.2.3 Ventilators
- 9.1.2.4 Inhalers
- 9.1.2.5 Nebulizers
- 9.1.2.6 Humidifiers
- 9.1.2.7 Reusable Resuscitators
- 9.1.2.8 Nitric Oxide Delivery Units
- 9.1.2.9 Oxygen Hoods
- 9.1.3 Respiratory Care Monitoring Devices
- 9.1.3.1 Pulse Oximeter
- 9.1.3.2 Capnography
- 9.1.3.3 Gas Analyzers
- 9.1.4 Diagnostic Respiratory Care Devices
- 9.1.4.1 Spirometer
- 9.1.4.2 Polysomnography Devices
- 9.1.4.3 Peak Flow Meter
- 9.1.4.4 Others
- 9.2 North America Respiratory Care Device Market (2018-2034) by Disease Indications
- 9.2.1 Market Overview
- 9.2.2 COPD
- 9.2.3 Asthma
- 9.2.4 Sleep Apnea
- 9.2.5 Infectious Disease
- 9.2.6 Others
- 9.3 North America Respiratory Care Device Market (2018-2034) by End User
- 9.3.1 Market Overview
- 9.3.2 Hospitals
- 9.3.3 Home Care
- 9.3.4 Ambulatory Care
- 9.3.5 Others
- 9.4 North America Respiratory Care Device Market (2018-2034) by Country
- 9.4.1 United States of America
- 9.4.2 Canada
- 10 Europe Respiratory Care Device Market (218-2034)
- 10.1 Europe Respiratory Care Device Market (2018-2034) by Product
- 10.1.1 Market Overview
- 10.1.2 Therapeutic Respiratory Care Devices
- 10.1.2.1 Positive Airway Pressure (PAP) Devices
- 10.1.2.2 Oxygen Concentrator
- 10.1.2.3 Ventilators
- 10.1.2.4 Inhalers
- 10.1.2.5 Nebulizers
- 10.1.2.6 Humidifiers
- 10.1.2.7 Reusable Resuscitators
- 10.1.2.8 Nitric Oxide Delivery Units
- 10.1.2.9 Oxygen Hoods
- 10.1.3 Respiratory Care Monitoring Devices
- 10.1.3.1 Pulse Oximeter
- 10.1.3.2 Capnography
- 10.1.3.3 Gas Analyzers
- 10.1.4 Diagnostic Respiratory Care Devices
- 10.1.4.1 Spirometer
- 10.1.4.2 Polysomnography Devices
- 10.1.4.3 Peak Flow Meter
- 10.1.4.4 Others
- 10.2 Europe Respiratory Care Device Market (2018-2034) by Disease Indications
- 10.2.1 Market Overview
- 10.2.2 COPD
- 10.2.3 Asthma
- 10.2.4 Sleep Apnea
- 10.2.5 Infectious Disease
- 10.2.6 Others
- 10.3 Europe Respiratory Care Device Market (2018-2034) by End User
- 10.3.1 Market Overview
- 10.3.2 Hospitals
- 10.3.3 Home Care
- 10.3.4 Ambulatory Care
- 10.3.5 Others
- 10.4 Europe Respiratory Care Device Market (2018-2034) by Country
- 10.4.1 United Kingdom
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 Italy
- 10.4.5 Others
- 11 Asia Pacific Respiratory Care Device Market (218-2034)
- 11.1 Asia Pacific Respiratory Care Device Market (2018-2034) by Product
- 11.1.1 Market Overview
- 11.1.2 Therapeutic Respiratory Care Devices
- 11.1.2.1 Positive Airway Pressure (PAP) Devices
- 11.1.2.2 Oxygen Concentrator
- 11.1.2.3 Ventilators
- 11.1.2.4 Inhalers
- 11.1.2.5 Nebulizers
- 11.1.2.6 Humidifiers
- 11.1.2.7 Reusable Resuscitators
- 11.1.2.8 Nitric Oxide Delivery Units
- 11.1.2.9 Oxygen Hoods
- 11.1.3 Respiratory Care Monitoring Devices
- 11.1.3.1 Pulse Oximeter
- 11.1.3.2 Capnography
- 11.1.3.3 Gas Analyzers
- 11.1.4 Diagnostic Respiratory Care Devices
- 11.1.4.1 Spirometer
- 11.1.4.2 Polysomnography Devices
- 11.1.4.3 Peak Flow Meter
- 11.1.4.4 Others
- 11.2 Asia Pacific Respiratory Care Device Market (2018-2034) by Disease Indications
- 11.2.1 Market Overview
- 11.2.2 COPD
- 11.2.3 Asthma
- 11.2.4 Sleep Apnea
- 11.2.5 Infectious Disease
- 11.2.6 Others
- 11.3 Asia Pacific Respiratory Care Device Market (2018-2034) by End User
- 11.3.1 Market Overview
- 11.3.2 Hospitals
- 11.3.3 Home Care
- 11.3.4 Ambulatory Care
- 11.3.5 Others
- 11.4 Asia Pacific Respiratory Care Device Market (2018-2034) by Country
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 ASEAN
- 11.4.5 Australia
- 11.4.6 Others
- 12 Latin America Respiratory Care Device Market (218-2034)
- 12.1 Latin America Respiratory Care Device Market (2018-2034) by Product
- 12.1.1 Market Overview
- 12.1.2 Disposable Sensors
- 12.1.3 Reusable Probes
- 12.2 Latin America Respiratory Care Device Market (2018-2034) by Product Type
- 12.2.1 Market Overview
- 12.2.2 Therapeutic Respiratory Care Devices
- 12.2.2.1 Positive Airway Pressure (PAP) Devices
- 12.2.2.2 Oxygen Concentrator
- 12.2.2.3 Ventilators
- 12.2.2.4 Inhalers
- 12.2.2.5 Nebulizers
- 12.2.2.6 Humidifiers
- 12.2.2.7 Reusable Resuscitators
- 12.2.2.8 Nitric Oxide Delivery Units
- 12.2.2.9 Oxygen Hoods
- 12.2.3 Respiratory Care Monitoring Devices
- 12.2.3.1 Pulse Oximeter
- 12.2.3.2 Capnography
- 12.2.3.3 Gas Analyzers
- 12.2.4 Diagnostic Respiratory Care Devices
- 12.2.4.1 Spirometer
- 12.2.4.2 Polysomnography Devices
- 12.2.4.3 Peak Flow Meter
- 12.2.4.4 Others
- 12.3 Latin America Respiratory Care Device Market (2018-2034) by Disease Indications
- 12.3.1 Market Overview
- 12.3.2 COPD
- 12.3.3 Asthma
- 12.3.4 Sleep Apnea
- 12.3.5 Infectious Disease
- 12.3.6 Others
- 12.4 Latin America Respiratory Care Device Market (2018-2034) by End User
- 12.4.1 Market Overview
- 12.4.2 Hospitals
- 12.4.3 Home Care
- 12.4.4 Ambulatory Care
- 12.4.5 Others
- 12.5 Latin America Respiratory Care Device Market (2018-2034) by Country
- 12.5.1 Brazil
- 12.5.2 Argentina
- 12.5.3 Mexico
- 12.5.4 Others
- 13 Middle East and Africa Respiratory Care Device Market (218-2034)
- 13.1 Middle East and Africa Respiratory Care Device Market (2018-2034) by Product
- 13.1.1 Market Overview
- 13.1.2 Therapeutic Respiratory Care Devices
- 13.1.2.1 Positive Airway Pressure (PAP) Devices
- 13.1.2.2 Oxygen Concentrator
- 13.1.2.3 Ventilators
- 13.1.2.4 Inhalers
- 13.1.2.5 Nebulizers
- 13.1.2.6 Humidifiers
- 13.1.2.7 Reusable Resuscitators
- 13.1.2.8 Nitric Oxide Delivery Units
- 13.1.2.9 Oxygen Hoods
- 13.1.3 Respiratory Care Monitoring Devices
- 13.1.3.1 Pulse Oximeter
- 13.1.3.2 Capnography
- 13.1.3.3 Gas Analyzers
- 13.1.4 Diagnostic Respiratory Care Devices
- 13.1.4.1 Spirometer
- 13.1.4.2 Polysomnography Devices
- 13.1.4.3 Peak Flow Meter
- 13.1.4.4 Others
- 13.2 Middle East Africa Respiratory Care Device Market (2018-2034) by Disease Indications
- 13.2.1 Market Overview
- 13.2.2 COPD
- 13.2.3 Asthma
- 13.2.4 Sleep Apnea
- 13.2.5 Infectious Disease
- 13.2.6 Others
- 13.3 Middle East and Africa Respiratory Care Device Market (2018-2034) by End User
- 13.3.1 Market Overview
- 13.3.2 Hospitals
- 13.3.3 Home Care
- 13.3.4 Ambulatory Care
- 13.3.5 Others
- 13.4 Middle East and Africa Respiratory Care Device Market (2018-2034) by Country
- 13.4.1 Saudi Arabia
- 13.4.2 United Arab Emirates
- 13.4.3 Nigeria
- 13.4.4 South Africa
- 13.4.5 Others
- 14 Regulatory Framework
- 14.1 Regulatory Overview
- 14.2 US FDA
- 14.3 EU EMA
- 14.4 INDIA CDSCO
- 14.5 JAPAN PMDA
- 14.6 Others
- 15 Patent Analysis
- 15.1 Analysis by Type of Patent
- 15.2 Analysis by Publication Year
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Patent Age
- 15.5 Analysis by CPC Analysis
- 15.6 Analysis by Patent Valuation
- 15.7 Analysis by Key Players
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Strategic Initiatives
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 Market Share Analysis, By Region (Top 5 Companies)
- 18.1.1 Market Share Analysis: Global
- 18.1.2 Market Share Analysis: North America
- 18.1.3 Market Share Analysis: Europe
- 18.1.4 Market Share Analysis: Asia-Pacific
- 18.1.5 Market Share Analysis: Others
- 18.2 Koninklijke Philips N.V
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 Masimo Corporation
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Teleflex Incorporated
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 Fisher & Paykel Healthcare Corporation Limited
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 Hamilton Medical AG
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 ICU Medical Inc.
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 General Electric Company
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 ResMed Inc.
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 Getinge AB
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 18.11 Aerin Medical Inc.
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Mergers and Acquisitions
- 18.11.5 Certifications
- 18.12 VitalAire Canada Inc.
- 18.12.1 Financial Analysis
- 18.12.2 Product Portfolio
- 18.12.3 Demographic
- 18.12.4 Mergers and Acquisitions
- 18.12.5 Certifications
- 19 Global Respiratory Care Device Market – Distribution Model (Additional Insight)
- 19.1 Overview
- 19.2 Potential Distributors
- 19.3 Key Parameters for Distribution Partner Assessment
- 20 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
